Contact

Home / Products / Liverscan®

AI-POCT Transient Elastography System

Liverscan® — Beyond Fibrosis. Complete Liver Intelligence.

The world’s exclusive 2D ultrasound real-time guided transient elastography patented technology pioneer.
Contact Us
Liverscan C handheld elastography device for clinical liver assessment workflows

Liverscan® C

Wireless probe plus portable workstation configuration

Liverscan Mobile wireless probe system for portable liver screening workflows

Liverscan® Mobile

Wireless probe plus software installed in flexible terminal

Product Overview

Liver Assessment. Anywhere Care Happens.

Liverscan® is a point-of-care liver assessment platform that brings together transient elastography, real-time B-mode guidance, a fully wireless probe, and MAP fat quantification — in a single, portable system.

Built for clinics, screening programs, and preventive care, it makes liver fibrosis and steatosis assessment faster, simpler, and more consistent — without compromising accuracy.

Product Facts

Measures

Liver stiffness (LSM) and fat quantification (MAP) in one exam.

Efficiency

Reliable results from just 4 valid measurements. Twice the Efficiency vs conventional workflow.

Guidance

B-mode ultrasound ensures every measurement hits the right spot.

Wireless

No cables. Place the probe wherever the patient is.

Flexible

Liverscan® C and Liverscan® Mobile share the same probe — different form factors, identical performance.

liver elastography for clinical trials

From Repeated Attempts to Guided, Efficient Measurement

Conventional TE Workflow

Constrained by positioning and repetition

Blind / operator-dependent positioning
Repeated attempts
10 valid measurements
Cart-room or limited mobility workflows
Circular workflow graphic showing liver assessment challenge and diagnostic pathway

Liverscan® Workflow

Guided, wireless, and designed for point of care liver elastography

Real-time B-mode guidance
Targeted measurement region
4 valid measurements
Portable deployment across care settings

Clinical value

Improves measurement confidence through visual guidance.

Workflow value

Reduces unnecessary repeated measurement attempts.

Access value

Supports mobile and distributed liver assessment programs.

Coverage value

Combines stiffness and fat assessment in one product line.

Our solution

Liver Stiffness and Fat Measurement for Hepatic Fibrosis and Steatosis

Liverscan® combines point-of-care transient elastography, real-time B-mode guidance, and integrated AI to support clinically validated fibrosis and steatosis assessment. 

By the way, It’s not a lab concept — it is a clinically validated medical device backed by world-leading hepatologists and published in one of the most prestigious hepatology journals in the world.

1,455 + 138

Patients Compared with FibroScan® and Biopsy

Head-to-head comparison cohort for liver assessment validation.

r=0.86/0.80

Liver Stiffness Measurement (LSM) / Fat Quantification Correlation

Liverscan® is statistically non-inferior to FibroScan®.

AUROC 0.97

Cirrhosis (F4) Detection

Near perfect cirrhosis detection.

AUROC 0.92

Fatty Liver (≥S1) Screening

An exceptionally accurate tool for detecting steatosis.

Liver International     Original Research Article

DOI: https://doi.org/10.1111/liv.70634

Applicable Liver Conditions

Assessment Support Across Liver Disease Pathways

NAFLD / MASLD

Deliver real-time B-mode ultrasound guidance, liver stiffness measurement (LSM), and AI-powered fat quantification (MAP) in a single wireless handheld probe — enabling rapid steatosis grading and fibrosis staging for NAFLD/MASLD patients across endocrinology, primary care, and health screening workflows.

Fibrosis Assessment

With just 4 AI-guided measurements — half the requirement of conventional systems — Liverscan® provides diagnostic-grade liver stiffness evaluation for fibrosis staging, streamlining specialist and hospital-based hepatology workflows with doubled throughput and a dramatically shorter learning curve.

Chronic Viral Liver Disease

Offer a portable, non-invasive liver assessment for chronic hepatitis B and C patients — enabling serial liver stiffness assessment for fibrosis progression tracking in both tertiary hospital and community-based care settings.

Alcohol-related Liver Risk

Provide rapid, point-of-care liver stiffness and fat quantification in under one minute — an accessible, non-invasive screening tool for alcohol-related liver disease across broader liver health programs, from primary care to corporate wellness and insurance risk stratification.

Technology Architecture

One Platform for Guided Liver Assessment

Real-time B-mode Guidance

Improves targeting precision during transient elastography examinations.

Transient Elastography

Supports liver stiffness measurement for fibrosis assessment workflows.

Ultrasound measurement interface displaying liver stiffness and attenuation assessment results

Probe + Software + AI Processing Layers

MAP Fat Quantification

32-line two-dimensional sampling supports hepatic fat quantification.

AI-assisted Analysis

Supports quality control, parameter adaptation, and measurement consistency.

Clinical Workflow

Liver Elastography Procedure

01

Target

Transient elastography imaging with real-time B-mode ultrasound guidance provides live anatomical visualization — enabling operators to visually confirm the optimal intercostal window before every acquisition, eliminating the blind sampling inherent to conventional TE.

02

Measure

The wireless handheld probe performs transient elastography and ultrasound attenuation measurement in a single acquisition — capturing liver stiffness (LSM) and fat quantification (MAP) simultaneously, in under one minute.

03

Analyze

Four purpose-built AI models run in real time: Elastogram Quality Assessment, Shear Wave Trajectory Detection, Auto Measurement Mode Selection, Liver Boundary Segmentation — ensuring diagnostic-grade consistency across operators and clinical settings.
04

Report

LSM and MAP results are generated on-device in real time — delivering fibrosis stage and steatosis grade in a structured, actionable report with no post-processing, no cloud dependency, and no waiting.

Clinical workflow illustration for guided liver screening and reporting process

Eieling liver assessment device comparison

Same Liverscan® Platform, Different Deployment Styles

Flagship Model

Liverscan handheld probe and tablet system for liver elastography testing

Liverscan® C

Wireless probe plus portable liver elastography system with pre-installed software, touch screen, bluetooth keyboard, wireless charging slot, usb ports, type-c port, and optional backpack.

Entry Model

Liverscan mobile device showing compact portable liver assessment hardware design

Liverscan® Mobile

Wireless probe plus flexible software installation package for laptop/ surface with recommended software running minimum system configuration.

Shared probe foundation

Liverscan® C and Liverscan® Mobile use the same probe parameters and differ mainly by workstation setup and deployment scenario.

Care Settings

Designed for Clinical and Screening Pathways

Care Setting
Primary Need
Liverscan® Value
Primary Audience
Hepatology & Gastroenterology
Comprehensive fibrosis staging and chronic liver disease surveillance — HBV/HCV, MASLD/MASH, pre-treatment baseline

Real-time B-mode visual targeting ensures every measurement lands on valid liver parenchyma. 4 AI-guided acquisitions deliver diagnostic-grade LSM and MAP in under 1 minute

Hepatology units, GI departments, Liver transplant centers, Academic medical centers
Primary care & GP & Private clinics
First-line metabolic liver risk screening and same-visit referral triage
Handheld, cart-free — fits any consultation room. B-mode guidance reduces operator dependency; immediate LSM and fat results enable on-the-spot risk stratification and informed referral decisions without sending patients elsewhere.
GP practices, private medical clinics, Polyclinics, Community care networks
Health management centers & Medical imaging center
High-throughput liver health screening with standardized, trackable reporting
4 AI-powered quality-assurance models ensure operator-independent consistency at scale. Structured digital reports with longitudinal tracking — one device supports hundreds of exams per day without calibration drift or inter-operator variability.
Health screening chains, Medical imaging centers, Corporate wellness providers, Private medical groups
Community-based chronic disease outreach
Bringing specialist-grade liver diagnostics to underserved and remote populations
Wireless, battery-powered (4+ hours), zero infrastructure. Deploy in mobile screening vans, rural health posts, community centers — no cart, no dedicated room, no power dependency. Same diagnostic accuracy as a hospital hepatology unit.
Public health programs, Mobile screening units, Rural clinics, NGO-led disease elimination initiatives

Specifications

Technical Details for Evaluation

Category
Specification
Clinical Value

Liver Stiffness Measurement (LSM)

Transient elastography, 3.5 MHz probe, 1.5–75 kPa range
Fibrosis staging with 4 measurements, not 10. AUROC 0.97 for cirrhosis detection, r=0.86 vs. FibroScan® — diagnostic-grade confidence in under 1 minute.

MAP Fat Quantification

AI-driven ultrasound attenuation, 100–400 dB/m, trained on 10,000+ clinical cases
Steatosis grading correlated with MRI-PDFF (Pilot study). AUROC 0.92 for fatty liver screening, r=0.80 vs. FibroScan®. Enables GLP-1 therapy monitoring, MASLD progression tracking, and treatment response assessment — all at the point of care.
B-mode Real-time Guidance
Integrated 2D ultrasound visualization in the wireless probe
Operators see the liver before they measure it. Eliminates the blind sampling of conventional TE — higher first-pass success rates, fewer failed acquisitions, especially in abdominal obesity patients.
Wireless Handheld Probe
All-in-one composite probe, 4+ hour battery, no external cart
Deploy anywhere. Hospital wards, outpatient clinics, community screening vans, remote settings. No dedicated room. No power outlet hunt. No infrastructure dependency.

RECOGNITION

Awards & Patented Technologies

2022

Inaugural BOCHK Science and Technology Innovation Prize

Recognition from Bank of China (Hong Kong) connected to technology innovation.

2021

Silver Award, International Exhibition of Inventions

Recognition from Geneva, Switzerland for invention and technology development.

CN101843501B

B-mode imaging-guided transient elastography.

US8147410B2

Ultrasound imaging and elasticity measurement.

CN307385892S

Composite probe design for wireless TE.

CN111772677A

Multi-dimensional tissue elasticity detection.

FAQ

Why is the probe designed to be a long bar?

Different from conventional probe type in round performing stiffness detection function only, without B ultrasound image real-time guidance function. We are composite probe with B ultrasound image real-time guidance function. Liverscan is not only composite probe but also multi-element probe, meaning multi-channel sampling, significantly improving clinical efficiency; it also reduces sampling errors at a single location.

What does the color box on the B-ultrasound image represent?

The ROI box with different colors automatically prompts the sampling area of liver stiffness and acoustic attenuation parameters, and intuitively locates the sampling area.

What is the function of the largest button on the probe?

Adjust the probe holding area [navigation button] to avoid obvious large blood vessels, cysts and other non-liver substance: Up/down button to adjust hardness measurement depth. Left/right button adjusts the radial position of hardness measurement.

Why does the pop-up measurement fail?

If the test fails, the measurement interface will pop up a window to prompt (the algorithm will automatically prompt and eliminate invalid measurement results). You can repeat the test after waiting for the window to close automatically.

Ready to bring liver health screening to your patients?

Contact